MediciNova Inc reports results for the quarter ended in March - Earnings Summary

Medicinova

10/05/2024 09:01

* MediciNova Inc  MNOV.OQ  reported a quarterly adjusted
loss of 6
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -7
cents.  The lone analyst forecast for the quarter was for a loss
of 5 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * MediciNova Inc's reported EPS for the quarter was a loss
of 6
cents​.
    * The company reported a quarterly loss of $2.76 million.
    * MediciNova Inc shares had risen by 0.7% this quarter and
lost 2.7% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MediciNova Inc is
$17.00 
This summary was machine generated from LSEG data May 10 at
08:00 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.05          -0.06          Missed
 Dec. 31 2023      -0.08          -0.04          Beat
 Sep. 30 2023      -0.08          -0.01          Beat
 Jun. 30 2023      -0.07          -0.06          Beat